Medical cannabis, also known as medical marijuana, refers to cannabis products containing cannabinoids that physicians prescribe to patients.

According to the company, the new facility, the first of its kind in Costa Rica, is located in the Coris Industrial Zone in Cartago Province.

“This inauguration represents a historic milestone for the company, as it is our first major project and will allow us to move further toward achieving our goals in the industry,” said Jorge Calderón, the company’s general manager.

The laboratory will manufacture products including concentrates, oils, syrups, tablets and finished medicines made from Cannabis sativa. The products will be marketed in Costa Rica and exported to Germany, Switzerland and the United Kingdom.

As part of its initial operations, the company made its first export to Europe in March. The shipment consisted of raw materials for producing cannabis-derived pharmaceutical products and was carried out through Hybrida Farm, Vantage Point Global’s registered brand.

The company currently employs 85 people. With the new laboratory beginning operations, Vantage Point Global plans to create at least 400 additional jobs.

To boost exports, Costa Rica legalized the production of medical cannabis and hemp in 2022. However, recreational use, personal cultivation and personal consumption remain illegal.

In February 2025, the Ministry of Public Health issued a decree establishing technical regulations for medicinal products based on cannabis. The regulations permit the production, manufacturing and sale of medicines containing cannabis as an ingredient.

The Ministry of Public Health is the state-owned agency responsible for overseeing and regulating public and private health care in Costa Rica.

----------